Nothing Special   »   [go: up one dir, main page]

JPH0320206A - Skin cosmetic - Google Patents

Skin cosmetic

Info

Publication number
JPH0320206A
JPH0320206A JP15638589A JP15638589A JPH0320206A JP H0320206 A JPH0320206 A JP H0320206A JP 15638589 A JP15638589 A JP 15638589A JP 15638589 A JP15638589 A JP 15638589A JP H0320206 A JPH0320206 A JP H0320206A
Authority
JP
Japan
Prior art keywords
whey
skin
collagen synthesis
acid
skin cosmetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP15638589A
Other languages
Japanese (ja)
Other versions
JP2533376B2 (en
Inventor
Keizo Koyama
恵三 小山
Akio Kawasaki
川崎 昭男
Hidehisa Takahashi
秀久 高橋
Toshiro Hori
俊郎 堀
Masatsugu Yamashita
政続 山下
Katsuya Nishimoto
西元 勝也
Yoshinori Okuda
吉則 奥田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiyo Kagaku KK
Original Assignee
Taiyo Kagaku KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiyo Kagaku KK filed Critical Taiyo Kagaku KK
Priority to JP1156385A priority Critical patent/JP2533376B2/en
Publication of JPH0320206A publication Critical patent/JPH0320206A/en
Application granted granted Critical
Publication of JP2533376B2 publication Critical patent/JP2533376B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)

Abstract

PURPOSE:To obtain a skin cosmetic, containing mammalian whey having collagen synthesis accelerating action and fractionated ingredients thereof, capable of specifically accelerating the collagen synthesis of dermal fibroblasts and having senescence controlling function. CONSTITUTION:A skin cosmetic, obtained by blending whey of a mammal having collagen synthesis accelerating action, preferably human, cattle, goat, sheep or pig, especially in initial whey within 5 days after delivery and fractionated ingredients thereof, preferably an acid- and a alcohol-soluble fraction prepared by treating the whey with a solution at pH1-5 in 10-50% (vol./vol.) alcohol concentration, especially pH2.0-4.5 in 30-40% (vol./vol.) alcohol concentration and then removing insoluble substances as an essential ingredient in a skin cosmetic, such as toilet water, cream, milky lotion or pack and having senescence controlling function so as to accelerate skin function, prevent wrinkles or the skin and provide fine and moist skin with high safety.

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明はコラーゲン合成冗進作用を有する噛乳動物の乳
清及びその分画成分を含有することを特徴とする皮膚化
粧料(医薬部外品たる薬用化粧品を含む.以下同じ)に
関する. 〔従来の技術〕 老齢化社会を迎えつつあるわが国において、老化(エー
ジング)に対する医学的関心が高まる中、皮膚科領域に
おいても皮膚の老化メカニズム等に関する研究が進めら
れ、特に、細胞賦活剤の投与による老化制御に内外の注
目が集まっている.従来、いくつかの動植物及び菌類の
抽出物に組織賦活能が認められ、医薬品や化粧品に用い
られてきた.しかしこれらのものの中で、細胞レベルに
おいて生理活性を有する物質として評価されたものは少
なく、例えば、組織切片に対するこれらの抽出物の添加
による#素の消費量の増加を、ワールプルグ検圧計等を
用いて測定する方法、あるい祉また、ATP等の酸化的
リン酸化を触媒するような酵素を用いた定量法が試みら
れている.しかしながら、これらの手段では、例えば、
組織切片を用いた酸素消費量試験法によれば、水もまた
賦活能を示し、極端なことを言えば炭素や窒素源′をも
った多くのものは適量の濃度にあって酸素の消費量の増
加を示す.少なくとも栄養剤としての評価にはこれらの
測定手段は有効であるが、細胞レベルで皮膚の機能をと
らえ検体の評価を行なうとき、これらの手段により細胞
賦活薫をとらえることは無理な点が多かった. 〔発明が解決しようとする問題点〕 い抵抗力とを有することにより、その生理機能を充分に
果たしている. 皮膚を組織学的に大別すると、表皮、真庶、皮下組織に
分けられるが、特に真皮は皮膚の支持組織として、皮膚
の恒常性維持のために重要な役割を果たしている.真皮
の主な構成細胞は線維芽細胞であり、コラーゲン等の蛋
白質やヒアルロン酸などのグリコサミノグリカンを産生
し、これらの結合組織成分の中で構築構造を形成してい
る.加齢に伴う皮膚の形態的変化としては、まず、皮膚
組織の厚さの減少及び萎縮が知られている(Marks
.R. . Biochemistry and Ph
ysiology of theSkin. Oxfo
rd University Press. 1983
 Lまた、皮膚のねじれ伸張性は減少し、弾性回復力が
低下し、更にクルミが増し、やがて老人の皮膚にみられ
る最も特徴的変化であるところの皺(しわ)を形成する
に至る。
DETAILED DESCRIPTION OF THE INVENTION [Field of Industrial Application] The present invention relates to a skin cosmetic (non-medicinal) characterized by containing whey of a mammalian animal and its fractionated components, which have a collagen synthesis enhancing effect. (including high-quality medicated cosmetics (the same applies hereinafter)). [Prior art] In Japan, which is facing an aging society, medical interest in aging is increasing, and research into the mechanism of skin aging is progressing in the field of dermatology, with particular emphasis on the administration of cell activators. The control of aging is attracting attention at home and abroad. Extracts from several plants, animals, and fungi have been found to have tissue activating ability and have been used in pharmaceuticals and cosmetics. However, few of these substances have been evaluated as physiologically active substances at the cellular level. Attempts have also been made to measure oxidative phosphorylation using enzymes that catalyze oxidative phosphorylation of ATP, etc. However, with these means, e.g.
According to the oxygen consumption test method using tissue sections, water also shows activating ability, and to put it in an extreme case, many carbon and nitrogen sources have low oxygen consumption at appropriate concentrations. shows an increase in These measurement methods are effective at least for evaluation as nutritional supplements, but when assessing skin functions at the cellular level and evaluating samples, there are many points where it is impossible to use these methods to capture cell activation scent. .. [Problems to be solved by the invention] By having a strong resistance, it satisfactorily fulfills its physiological functions. Histologically, the skin can be roughly divided into the epidermis, dermis, and subcutaneous tissue, and the dermis in particular plays an important role in maintaining skin homeostasis as a support tissue for the skin. The main constituent cells of the dermis are fibroblasts, which produce proteins such as collagen and glycosaminoglycans such as hyaluronic acid, and form structural structures among these connective tissue components. The first known morphological changes in the skin associated with aging include a decrease in skin tissue thickness and atrophy (Marks
.. R. .. Biochemistry and Ph
ysiology of theSkin. Oxford
rd University Press. 1983
In addition, the torsional extensibility of the skin decreases, the elastic recovery power decreases, and the walnuts further increase, eventually leading to the formation of wrinkles, which are the most characteristic changes seen in the skin of the elderly.

一方、真皮の加齢に伴なって生じる最も大きな生化学変
化は、細胞外マトリックスの主成分であるコラーゲンに
認められる.即ち、皮膚コラーゲン量は20歳から80
歳までの間に65%減少し、真皮の厚さは薄くなる( 
Shuster.S. * BritishJourn
al of Dermato1ogy.93,639.
1975 ).また、コラーゲンの代謝回転率も加齢に
より低下し生体内に長時間存在するため、コラーゲンS
維中に無秩序な分子間架橋や糖化等が進行し、非可溶性
コラーゲンが増加し( Lagrand.Y.. Pa
thologicalBiology. 17. 99
1. 1969 )、細胞外マトリックスノ硬化の原因
となる. これらの研究の結果より、真皮1!雑芽細胞のコラーゲ
ン合成を特異的に冗進することができれば、真皮のコラ
ーゲン含有量が増加し真皮の厚さを増し、それに伴って
代謝回転も活性化され、可溶性コラーゲンが増加するこ
とにより細胞外マトリックスの柔軟性、伸展性を改善し
、その結果皺に代表される老化皮膚の形態的変化を抑制
できる可能性がある. 本発明は真皮の線雑芽細胞のコラーゲン合成を〔問題を
解決するための手段〕 本発明者らは、まず細胞レベルで、検体の評価を行なう
ため培養線維芽細胞を用いたコラーゲン合成能試馳法を
確立した. 即ち、本試験法は、培養面全体に単層を形成する直前の
状態( subconfluent )まで培養したヒ
ト線維芽細胞に、検体と同時に放射性同位元素で標識し
たプロリン((’H)一プロリン)を添加して更に培養
を続け細胞内に取り込ませた後、その培養土清と細胞画
分とから、一方で◆ま総蛋白質量として( ’H )一
プロリン量を、もう一方ではコラーゲナーゼ処理して得
られたトリクロロ酢酸(TCA)可溶画分の〔1H〕−
プロリン量を測定し、合成コラーゲン量を定量するもの
である。
On the other hand, the most significant biochemical changes that occur with aging in the dermis are observed in collagen, the main component of the extracellular matrix. In other words, the amount of collagen in the skin decreases to 80% from the age of 20.
By age, the thickness of the dermis decreases by 65%, and the thickness of the dermis becomes thinner (
Shuster. S. * British Journal
al of Dermatolology. 93,639.
1975). In addition, the turnover rate of collagen decreases with age and remains in the body for a long time, so collagen S
Disordered intermolecular cross-linking and saccharification progress in the fibers, and insoluble collagen increases (Lagland. Y. Pa.
thological Biology. 17. 99
1. (1969), which causes hardening of the extracellular matrix. From the results of these studies, dermis 1! If it were possible to specifically accelerate collagen synthesis in miscellaneous blast cells, the collagen content in the dermis would increase and the thickness of the dermis would increase, along with activation of turnover and increase in soluble collagen, which would lead to cell growth. It improves the flexibility and extensibility of the outer matrix, and as a result, it may be possible to suppress morphological changes in aging skin, such as wrinkles. The present invention aims to improve the collagen synthesis of dermal miscellaneous blast cells [Means for solving the problem] The present inventors first conducted a collagen synthesis ability test using cultured fibroblasts to evaluate the specimen at the cellular level. Established the method. In other words, in this test method, human fibroblasts that have been cultured to a state just before forming a monolayer on the entire culture surface (subconfluent) are injected with radioisotope-labeled proline (('H)-proline) at the same time as the specimen. After adding and further culturing to incorporate into the cells, the culture medium and cell fraction were treated with ◆ and ('H) monoproline as the total protein amount on the one hand, and collagenase treatment on the other hand. [1H]- of the trichloroacetic acid (TCA) soluble fraction obtained by
The amount of proline is measured and the amount of synthetic collagen is quantified.

本発明者らは、動植物及び菌類より任意に選んだ種々の
物質について、そのコラーゲン合成冗進作用を上述の試
験法にてスクリーニングした結果、呻乳動物の乳清及び
その分画成分に高いコラーゲン合成冗進活性を認めるに
至った。
The present inventors screened various substances arbitrarily selected from animals, plants, and fungi for their collagen synthesis stimulatory effects using the above-mentioned test method. Synthetic redundant activity was recognized.

乳清は乳汁からカゼインと脂肪を除去した後に残る画分
て、牛乳からはチーズやカゼイン製造時の副産物として
得られる.また古代ギリシャではヒボクラテスにより自
然薬の一つとして、体の洗浄、利尿、解毒、機能増進、
体力向復、便秘の治療などに万能薬的食品として乳清が
利用されていた.現在でも乳清は飲料等に利用され、特
に栄養生理学、予防医学的にその意義が認められている
.また、乳清まり得られる蛋白質(ホエーたんぱく濃縮
物.wpc)は、そのゲル形成性、保水性などの優れた
機能特性からハム、ソーセージ等加工食品向けに需要が
ある. しかしながら、これまで噛乳動物の乳清及びその分画成
分のコラーゲン合成冗進作用、またはその皮膚化粧料へ
の配合における有用性に関する研究は全くなされておら
ず、本発明者らにより初めて明らかにされたものである
. 即ち、哺乳動物の乳清のコラーゲン合成冗進作用は、分
娩後5日以内の初乳清に特に高く認めら動物の乳清及び
その分画成分を配合した皮膚化粧料を調製し皮膚に塗布
したところ、皮膚機能を冗進し、肌の皺を防止し、きめ
細やかな、かつしっとりした皮膚にすることを発見し、
また、その高い安全性を確認したため、本発明を完成す
るに至った.なお、本発明のコラーゲン合成充進作用を
有する噛乳動物の乳清及びその分画成分を配合した皮膚
化粧料は、真皮の線維芽細胞のコラーゲン合成を特異的
に冗進することにより、その効果をあらわすものと考え
られた. また、本発明の皮膚化粧料は組織損傷時、創床部に遊走
したam芽細胞により形成される肉芽組織に作用し、そ
のコラーゲン合成を先進し真皮の再構成を促すことによ
り創傷治癒効果を有することも期待される. 即ち、本発明は、コラーゲン合成冗進作用を有する哺乳
動物の乳清及びその分画成分を含有することを特徴とす
る新規な皮膚化粧料を提供するものである. 以下、本発明につき詳述する. 本発明に至る過程で用いた先述のコラーゲン合成能試験
法は本発明のコラーゲン合成冗進作用を制限するもので
はなく、細胞レベルでコラーゲン合成能を検出し得る他
の試験法、例えば、放射性同位元素で標識したヒドロキ
シブロリンを用いる方法、コラーゲンの抗体を用いる免
疫学的方法、コラーゲンのmRNAを核酸プロープとハ
イプリダイズさせ検出する方法等をin vitro,
 in vivo, in aituで利用することが
できる.本発明に使用する乳清は、まず、ヒト、ウシ、
ヤギ、ヒツジ、ブタ等の哺乳動物から採取された新鮮な
乳汁、或いはその乳汁を予め乾燥粉末化した後水に溶解
したものが用いられ、通常、遠心分離によって最上層の
脂肪分を除いて脱脂後、種々の方法でカゼイン画分を除
去し得られる.カゼイン画分の除去法は通常、大きく二
つの方法に分けられる.一つは乳酸、塩酸、硫酸等の酸
の添加に.J:’)pH4.4〜4.6程度の酸性でカ
ゼインを等電点沈殿させ、もう一つはキモシン等の酵素
の作用によりカゼインを凝固させ、いずれも不溶化した
カゼイン画分を濾過、遠心分離或いはデヵンテーション
等により除去する方法で行なわれ、得られるカゼイン画
分は、前者を酸カゼイン、後者をレンネットカゼインと
呼ぶ. なお、噛乳動物の分娩後5日以内に採取される初乳から
得られる初乳清中のコラーゲン合成冗進作用が、特に高
いことが明らかとなり、従来、初乳中にはグロプリン含
量が多いことが知られていることからも、生理学上、重
要な意味をもつものと考えられる. 更に本発明者らは、乳清中のコラーゲン合成冗進作用の
分画法につき研究した結果、乳清の酸・アルコール処理
により可溶画分に効率的に移行することを発見した.ま
た、得られた酸・アルコール可溶画分は清澄で安定な溶
液であり、皮膚化粧料想方上、その原料として有利な性
状であり、更に蛋白質等、アレルゲンとなりうる高分子
物質濃度が著しく低減されるため、安全性も向上する。
Whey is the fraction that remains after casein and fat are removed from milk, and is obtained from milk as a by-product during the production of cheese and casein. In ancient Greece, Hibocrates used it as a natural medicine to cleanse the body, diuretic, detoxify, and improve function.
Whey was used as a panacea for improving physical strength and treating constipation. Even today, whey is used in beverages and other products, and its significance is particularly recognized in terms of nutritional physiology and preventive medicine. In addition, the protein obtained from whey (whey protein concentrate.wpc) is in demand for processed foods such as ham and sausages due to its excellent functional properties such as gel-forming and water-retaining properties. However, until now, no research has been conducted on the collagen synthesis enhancing effect of whey from chewing mammals and its fractionated components, or on its usefulness in blending into skin cosmetics. This is what was done. In other words, the collagen synthesis enhancing effect of mammalian whey is particularly high in colostrum produced within 5 days after delivery.A skin cosmetic containing animal whey and its fractionated components is prepared and applied to the skin. They discovered that it enhances skin function, prevents wrinkles, and makes skin smooth and moisturized.
Furthermore, we have confirmed its high safety, which led us to complete the present invention. The skin cosmetics of the present invention containing mammalian whey and its fractionated components that have collagen synthesis-enhancing effects specifically enhance the collagen synthesis of fibroblasts in the dermis. This was thought to indicate an effect. In addition, the skin cosmetic of the present invention acts on the granulation tissue formed by amblasts that have migrated to the wound bed at the time of tissue damage, advances collagen synthesis, and promotes dermal reorganization, thereby exerting a wound healing effect. It is also expected that That is, the present invention provides a novel skin cosmetic product characterized by containing mammalian whey and its fractionated components, which have a collagen synthesis enhancing effect. The present invention will be explained in detail below. The above-mentioned collagen synthesis ability test method used in the process leading to the present invention does not limit the collagen synthesis redundancy effect of the present invention, and other test methods that can detect collagen synthesis ability at the cellular level, such as radioisotope In vitro, methods using hydroxybroline labeled with elements, immunological methods using collagen antibodies, and detection methods by hybridizing collagen mRNA with nucleic acid probes, etc.
It can be used in vivo and in situ. The whey used in the present invention is first of all human, bovine,
Fresh milk collected from mammals such as goats, sheep, and pigs, or milk that has been previously dried and powdered and then dissolved in water, is used, and is usually defatted by removing the fat in the top layer by centrifugation. After that, the casein fraction can be removed using various methods. Methods for removing casein fractions are generally divided into two main methods. One is for adding acids such as lactic acid, hydrochloric acid, and sulfuric acid. J:') Casein is isoelectrically precipitated with acidic pH of about 4.4 to 4.6, and casein is coagulated by the action of enzymes such as chymosin, and the insolubilized casein fraction is filtered and centrifuged. It is removed by separation or decantation, and the resulting casein fractions are called acid casein and rennet casein. In addition, it has been revealed that colostrum obtained from colostrum collected within 5 days after parturition of chewing mammals has a particularly high collagen synthesis enhancing effect, and conventionally, colostrum contains a high globulin content. Since this is known, it is considered to have important physiological significance. Furthermore, as a result of research into a fractionation method for collagen synthesis redundancy in whey, the present inventors discovered that whey is efficiently transferred to a soluble fraction by acid/alcohol treatment. In addition, the obtained acid/alcohol soluble fraction is a clear and stable solution, which is advantageous as a raw material for skin cosmetics, and the concentration of polymeric substances such as proteins that can be allergens is significantly reduced. This also improves safety.

以下に酸・アルコール想理条件につき詳細に説明するが
、本質的に呻乳動物の乳清に存在するコラーゲン合成冗
進作用成分は、種々の方法、例えば、脱乳糖、脱塩、溶
剤分画、塩析、限外濾過、ゲル濾過、イオン交換法等に
よっても分画、精製或いは濃縮することができる. 本発明の乳清の酸・アルコール可溶画分の調製に当って
は、まず、上述にある如く調製された乳清、或いはその
乳清を予め乾燥粉末化された後水に溶解したものを用い
、酸及びアルコールを別々に加えるか、または酸・アル
コール混液として加え、最終pH1〜5、アルコール濃
度10〜50%(V/V)好ましくはpH2.0〜4.
5、7 4 −z−ル濃度30〜40%(V/V)に調
整する.pH1未満、またはアルコール濃度50%(V
/v)以上では、コラーゲン合成冗進作用の作用成分が
失活或いは不溶化を起こす。また、pH5以上またはア
ルコール濃度10%(v/V)以下、或い辻酸もしくは
アルコールのどちらか一方だけの処理では、不等の方法
により濃縮してもよく、また、凍結乾燥、噴霧乾燥或い
は平板乾燥等の方法により乾燥粉末化することも可催で
ある. 本発明の皮膚化粧料は、化粧水、クリーム、乳液、パッ
クなど外用可能な任意の剤形であってよく、コラーゲン
合成冗進作用を有する呻乳動物の乳清及びその分画成分
の配合量も、症状の程度、剤形などによって適宜変更で
きる.また、その基エタノール、インプロパノール、n
−ブタノール等任意のものが用いられるが、好ましくは
エタノールが用いられる.また、使用する酸も塩酸、酢
酸、乳酸、硫酸、クエン酸、リン酸等特に限定するもの
ではない.酸・アルコール処理の結果、生じる不溶物は
濾過、遠心分離或いはデカンテーション等により除去し
、.コラーゲン合成冗進作用成分を豊富に含有する可溶
画分が得られる.更に、酸・アルコール可溶画分は必要
に応じてpHを中性に調整し、減圧濃縮、限外濾過或い
は凍結濃縮とができる. 〔作用〕 かくして得られる本発明の皮膚化粧料の有効性及び安全
性について試験した結果は、次のとおりである. 隻鷺適1 培養w&維芽細胞のコラーゲン合成能試験 継代維持してきたW4−38細胞(ヒト胎児肺正常2倍
体細胞,PDL40)を、試験前日に新しいMEM培地
(10%牛胎児血清含有)に培地交換し24時間培養(
 precultura )後、培養上清に試料を添加
、〔aH〕−ブロリンを終濃度2μCiとなる様添加し
、6時間、5%Co,+95%Air.37℃で培養し
た.なお、試料無添加区を対照とした.その後培養上清
を取り除き、細胞画分にフラ〜ゲナーゼタイブN ( 
Worthington社製) 5 units/ml
を37℃,18時間作用させ、トウントしコラーゲン量
とした. なお、非コラーゲン蛋白質量は、フラーゲナーゼ無処理
の総〔1H〕−プロリン量からコラーゲン量を差し引い
た値として表わした. その結果を第1表に示す. 試料の調製法と培地への試料添加量を下記する。
The acid/alcohol ideal conditions will be explained in detail below, but the collagen synthesis-enhancing components essentially present in the whey of mammalian animals can be processed by various methods, such as delactose, desalt, and solvent fractionation. It can also be fractionated, purified, or concentrated by salting out, ultrafiltration, gel filtration, ion exchange methods, etc. In preparing the acid/alcohol soluble fraction of whey of the present invention, first, the whey prepared as described above, or the whey that has been previously dried and powdered and then dissolved in water, is prepared. The acid and alcohol are added separately or as a mixture of acid and alcohol, with a final pH of 1 to 5 and an alcohol concentration of 10 to 50% (V/V), preferably a pH of 2.0 to 4.
5,7 Adjust the 4-z-le concentration to 30-40% (V/V). pH less than 1 or alcohol concentration 50% (V
/v) or higher, the active ingredient for collagen synthesis redundancy becomes inactivated or insolubilized. In addition, in cases where the pH is 5 or more, the alcohol concentration is 10% (v/v) or less, or only one of citric acid or alcohol is used, concentration may be performed by an unequal method, and freeze-drying, spray-drying, or It is also possible to dry and powder it by methods such as plate drying. The skin cosmetic of the present invention may be in any form that can be used externally, such as lotion, cream, milky lotion, or pack, and contains the amount of whey from a mammalian animal that has a collagen synthesis enhancing effect and its fractionated components. The dosage can also be changed as appropriate depending on the severity of symptoms, dosage form, etc. Also, its groups ethanol, inpropanol, n
-Any substance such as butanol can be used, but ethanol is preferably used. Furthermore, the acids used are not particularly limited, such as hydrochloric acid, acetic acid, lactic acid, sulfuric acid, citric acid, and phosphoric acid. Insoluble matter generated as a result of the acid/alcohol treatment is removed by filtration, centrifugation, decantation, etc. A soluble fraction rich in components that enhance collagen synthesis can be obtained. Furthermore, the pH of the acid/alcohol soluble fraction can be adjusted to neutrality if necessary, and the fraction can be concentrated under reduced pressure, ultrafiltrated, or frozen. [Effect] The results of testing the effectiveness and safety of the skin cosmetics of the present invention thus obtained are as follows. 1. Collagen synthesis ability test of cultured w&fibroblasts W4-38 cells (human fetal lung normal diploid cells, PDL40), which have been maintained for generations, were added to fresh MEM medium (containing 10% fetal bovine serum) on the day before the test. ) and cultured for 24 hours (
precultura), the sample was added to the culture supernatant, [aH]-brolin was added to a final concentration of 2 μCi, and the mixture was incubated for 6 hours in 5% Co, +95% Air. Cultured at 37°C. In addition, the sample-free plot was used as a control. After that, the culture supernatant was removed, and the cell fraction was divided into furagenase type N (
Worthington) 5 units/ml
was allowed to act at 37°C for 18 hours, and the amount of collagen was determined by torn. The non-collagen protein amount was expressed as the value obtained by subtracting the collagen amount from the total [1H]-proline amount without fullagenase treatment. The results are shown in Table 1. The sample preparation method and the amount of sample added to the medium are described below.

試料A :1ラーゲン合成冗進作用を有するウシ乳清 ウシの脱脂粉乳(常乳)570gを脱イオン水4.51
と混合し、IM酢@700mj!を加えpH4.4に調
整し、2時間攪拌、5℃で一夜放置した後、遠心分離(
 700gx30min ) L,、その上清をセライ
ト濾過し清澄な乳清を得た。
Sample A: 1 Bovine whey with lagen synthesis redundancy effect 570 g of bovine skim milk powder (conventional milk) was mixed with 4.5 g of deionized water.
Mix with IM vinegar @700mj! was added to adjust the pH to 4.4, stirred for 2 hours, left overnight at 5°C, and then centrifuged (
700g x 30min) L, and the supernatant was filtered through Celite to obtain clear whey.

試料B コラーゲン合成充進作用を有するウシ初乳清 ウシの分娩後2〜3日経過時に採取された初乳10Nを
遠心分ll( 15000gX30min )t,、最
上層の脂肪分を除去した後、30℃に加温、適量のキモ
シンを加え2時間攪拌後、遠心分XI ( 720gx
30min)シ、その上清をメンプランフィルターにて
濾過し清澄な初乳清を得た。
Sample B: Bovine colostrum with collagen synthesis enhancing effect 10N of colostrum collected from cows 2 to 3 days after calving was centrifuged (15000g x 30min), after removing the fat in the uppermost layer, ℃, add an appropriate amount of chymosin, stir for 2 hours, and centrifuge XI (720 g
30 min), and the supernatant was filtered using a Membrane filter to obtain clear colostrum.

試料C コラーゲン合成充進作用を有するウシ乳清の分
画或分 試料Aで得られたウシ乳清5lを減圧下、10倍濃縮し
、4℃まで冷却した時析出する乳糖を除いた後、水を加
え5lまで戻した.これにエタノール2.82と濃塩酸
60m2との混合液を加え、ホモミキサーで2時間混和
した.その後遠心分離( 700gx30min )L
,、その上清6lにIN+,酸化ナトリウム0.21を
加えpH7.0とし、減圧下、22まで濃縮し濾過して
清澄な乳清分画成分を得た. 試料D コラーゲン合成光進作用を有するウシ初乳清の
分画成分 試料Bで得られたウシ初乳清5Qにメタノール32を混
和し、酢酸でpH3.0とし、更にホモミキサーで2時
間混合した.その後デカンテーションにて上清を分取し
、分画分子量1万の限外濾過膜で2倍濃縮し、セライト
濾過により清澄な初乳清分画成分を得た. 試料E コラーゲン合成冗進作用を有するヤギ乳清の分
画成分 ヤギより採取された乳汁102を遠心分II( 150
00gx30min ) t,、最上層の脂肪分を除去
した後、乳酸を加えpH4 .5に調整し、2時間攪拌
、5℃で一夜放置した後、遠心分離( 700gx30
min ) L,、その上清をセライト濾過し清澄な乳
清を得た.この乳清61にn−プタノール3.42と酢
酸70mlの混液を加え、その後遠心分離( 700g
X30sin)L、その上清42にIN水酸化ナトリウ
ムを加えpH6.5とし、減圧下31まで濃縮し濾過し
て清澄な乳清分画成分を得た。
Sample C: Fractionation of bovine whey that has the effect of promoting collagen synthesis. 5 liters of the bovine whey obtained in Sample A was concentrated 10 times under reduced pressure, and after removing the lactose that precipitated when cooled to 4°C, Add water to bring the volume back up to 5 liters. A mixture of 2.82 ml of ethanol and 60 m2 of concentrated hydrochloric acid was added to this, and mixed for 2 hours using a homomixer. Then centrifugation (700g x 30min)
,, IN+, sodium oxide 0.21 was added to 6 liters of the supernatant to adjust the pH to 7.0, and the mixture was concentrated under reduced pressure to 22 and filtered to obtain a clear whey fraction. Sample D Fractionated component of bovine colostrum having collagen synthesis photostimulation activity Bovine colostrum 5Q obtained in sample B was mixed with methanol 32, adjusted to pH 3.0 with acetic acid, and further mixed for 2 hours in a homomixer. Thereafter, the supernatant was collected by decantation, concentrated twice using an ultrafiltration membrane with a molecular weight cutoff of 10,000, and filtered through Celite to obtain a clear colostrum fraction. Sample E Fractional component of goat whey that has a collagen synthesis enhancing effect Milk 102 collected from a goat was centrifuged with
00g x 30min) t, After removing the fat from the top layer, add lactic acid and adjust to pH 4. 5, stirred for 2 hours, left overnight at 5℃, and centrifuged (700g x 30℃).
min) L, the supernatant was filtered through Celite to obtain clear whey. A mixture of 3.42 ml of n-butanol and 70 ml of acetic acid was added to this whey 61, and then centrifuged (700 g
X30sin)L, its supernatant 42 was adjusted to pH 6.5 by adding IN sodium hydroxide, concentrated under reduced pressure to 31 and filtered to obtain a clear whey fraction.

試料F コラーゲン合成冗進作用を有するヒッジ乳清 ヒツジより採取された乳汁102を遠心分離(1500
0gX30min ) I,、最上層の脂肪分を除去し
た後IM塩酸1.12を加えpH4 .5に調整し、2
時間攪拌、5℃で一夜放置した後、遠心分離(700g
X30min ) シ、その上清をセライト濾過し清澄
な乳清を得た. 添加量(V/V培地X) 試料A:      5% 試料B:     5% 試料C:     2% 試料D=     2% 試料E:      2% 試料F:     5% 簸1遺 第1表より明らかな様に嘘乳動物の乳清及びその分画或
分は、線維芽細胞のコラーゲン合成を有意に、また特異
的に冗進することが明らかとなった. 区致班1 バネルテスト 小皺の悩みを有する31〜52歳(平均年齢40.1歳
)の女性50名を対象にして、下記の本発明皮膚化粧料
及び対照皮膚化粧料を、1日2回(朝、夕)連続3ケ月
塗布、使用せしめた結果の官能評価を第2表に示す. 〈本発明皮膚化粧料及び対照皮膚化粧料〉試験例1の試
料A (対照皮膚化粧料は精製水)      202グリセ
リン             5xエタノール   
            5zメチルパラベン    
        0.1x精製水          
     69.9X皐:対照との間に信頼度99%で
有意差あり(n=4)第2表より明らかな様に、本発明
の皮膚化粧料は高い有効性を示すことが明らかとなった
.莱1貞 較捩班1 パッチテスト 年齢21〜64歳までの男性17名、女性13名、計3
0名からなる被検者の上腕屈側部に、クローズドパッチ
テストを実施した.試料として実施例1のウシ乳清を用
いた. 判定の基準 −:全く無反応,±:軽微な紅斑,十;明
らかな紅斑,++;紅斑及び腫張、丘疹その結果、全被
検者において、一(全←無反応)であり、刺激反応及び
アレルギー反応を惹起する可能性は非常に少なく、安全
性の高いことが明らかとなった. 〔実施例〕 以下に本発明の実施例を示すが、これらによって本発明
を制限するものではない. 裏集負ユ 〈化粧水〉 グリセリン              5xプロビレ
ングリコール          4z才レイルアルコ
ール          0.1xボリオキシエチレン
ソルビタンモノラウリ1.5Xン酸エステル ボリ才キシエチレンラウリルエーテル  0.5xエタ
ノール               10x試験例1
の試料A            20%香料,染料,
防腐剤,紫外線吸収剤    適量精製水      
          58.92犬蓋輿1 〈クリーム〉 ステアリン酸 ステアリルアルコール 還元ラノリン スクワラン 才クチルドデカノール ポリ才キシエチレンセチルエーテル 親油型モノステアリン酸グリセリン プロピレングリコール 試験例1の試料B 香料,防腐剤,酸化防止剤 精製水 夫隻班1 く乳液〉 ステアリン酸 セタノール ワセリン ラノリンアルコール 流動パラフィン ボリ才キシエチレンモノ才レイ グリセリン 0.2x 1.5x 3x 2X 10X ン酸エステル2x 3x プロピレングリコール          5xトリエ
タノールアミン           1x試験例1の
試料C            15%香料,防腐剤,
#化防止剤        適量精製水       
         57.3X夾凰斑1 くパック〉 ポリビニルアルコール         15X力ルボ
キシメチルセルロースナトリウム  5xブロピレング
リコール          3xエタノール    
           10%試験例1の試料E   
          5X香料,防腐剤,酸化剤   
      適量精製水              
  62%〔発明の効果〕 以上詳述した如く、本発明のコラーゲン合成充進作用を
有する咄乳動物の乳清及びその分画成分を含有すること
を特徴とする皮膚化粧料は、皮膚機能を冗進し、肌の皺
を防止し、きめ細やかな、かつしっとりした皮膚にする
老化制御機能を有しまた安全性も高いため、 臨床上の応用が十分に 期待される. したがって、 本発明の産業上の意義 は非常に大きい.
Sample F: Milk 102 collected from a hedge whey sheep with collagen synthesis hyperactivity was centrifuged (1500
0g x 30min) I, After removing the fat from the top layer, add IM hydrochloric acid 1.12 to pH 4. Adjust to 5, then 2
After stirring for an hour and leaving it at 5℃ overnight, centrifugation (700g
x30min) The supernatant was filtered through Celite to obtain clear whey. Addition amount (V/V medium It has been revealed that whey from lying mammals and its fractions significantly and specifically enhance collagen synthesis in fibroblasts. Ward Team 1 Bunnell Test The following skin cosmetics of the present invention and control skin cosmetics were administered twice a day to 50 women aged 31 to 52 (average age: 40.1 years) suffering from fine wrinkles. Table 2 shows the sensory evaluation of the results of applying and using the product (morning and evening) for three consecutive months. <Skin cosmetics of the present invention and control skin cosmetics> Sample A of Test Example 1 (control skin cosmetics are purified water) 202 glycerin 5x ethanol
5z methylparaben
0.1x purified water
69.9X: There was a significant difference from the control with a confidence level of 99% (n = 4) As is clear from Table 2, it became clear that the skin cosmetics of the present invention showed high effectiveness. .. Patch test 17 men and 13 women between the ages of 21 and 64, total 3
A closed patch test was performed on the flexor side of the upper arm of 0 subjects. The bovine whey from Example 1 was used as a sample. Judgment criteria -: No reaction at all, ±: Slight erythema, 10: Obvious erythema, ++: Erythema and swelling, papules As a result, in all subjects, 1 (all ← no reaction), irritation reaction It has been found that the possibility of causing an allergic reaction is extremely low, and that it is highly safe. [Examples] Examples of the present invention are shown below, but the present invention is not limited by these. Back collection lotion Glycerin 5x Probylene glycol 4x Layl alcohol 0.1x Polyoxyethylene sorbitan monolauryl 1.5x Polyoxyethylene lauryl ether 0.5x Ethanol 10x Test example 1
Sample A 20% fragrance, dye,
Preservatives, UV absorbers Appropriate amount of purified water
58.92 Dog Cover 1 <Cream> Stearic acid stearyl alcohol reduced lanolin squalane cutyl dodecanol polyoxyethylene cetyl ether lipophilic monostearic acid glycerin propylene glycol Sample B of Test Example 1 Fragrance, preservative, antioxidant Purified Sailor Boat Group 1 Milky lotion> Stearic acid cetanol Vaseline Lanolin Alcohol Liquid paraffin Polyethylene glycerol 0.2x 1.5x 3x 2X 10X Phosphate ester 2x 3x Propylene glycol 5x Triethanolamine 1x Sample of Test Example 1 C 15% fragrance, preservative,
# Antioxidant Appropriate amount of purified water
57.3X scarlet 1 pack> Polyvinyl alcohol 15X Sodium carboxymethylcellulose 5x Bropylene glycol 3x Ethanol
Sample E of 10% Test Example 1
5X fragrance, preservative, oxidizing agent
Appropriate amount of purified water
62% [Effect of the invention] As detailed above, the skin cosmetic product of the present invention, which is characterized by containing whey of a mammalian mammal and its fractionated components, which has an effect of promoting collagen synthesis, improves skin function. It has aging control functions that prevent wrinkles and make the skin smooth and moisturized, and it is also highly safe, so it has high expectations for clinical application. Therefore, the industrial significance of the present invention is extremely large.

Claims (5)

【特許請求の範囲】[Claims] (1)コラーゲン合成亢進作用を有する哺乳動物の乳清
及びその分画成分を含有することを特徴とする皮膚化粧
(1) Skin cosmetics characterized by containing mammalian whey and fractionated components thereof that have a collagen synthesis enhancing effect
(2)哺乳動物がヒト、ウシ、ヤギ、ヒツジ、ブタであ
る特許請求の範囲第1項の皮膚化粧料
(2) The skin cosmetic according to claim 1, wherein the mammal is a human, cow, goat, sheep, or pig.
(3)乳清が分娩後5日以内の初乳清である特許請求の
範囲第1項の皮膚化粧料
(3) The skin cosmetic according to claim 1, wherein the whey is colostrum produced within 5 days after delivery.
(4)分画成分が酸・アルコール可溶画分である特許請
求の範囲第1項の皮膚化粧料
(4) The skin cosmetic according to claim 1, wherein the fractionated component is an acid/alcohol soluble fraction.
(5)酸・アルコール可溶画分がpH1〜5、アルコー
ル濃度10〜50%(V/V)で処理し、不溶物を除去
して得られる特許請求の範囲第4項の皮膚化粧料
(5) The skin cosmetic according to claim 4, which is obtained by treating the acid/alcohol soluble fraction at a pH of 1 to 5 and an alcohol concentration of 10 to 50% (V/V) to remove insoluble matter.
JP1156385A 1989-06-19 1989-06-19 Skin cosmetics Expired - Lifetime JP2533376B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP1156385A JP2533376B2 (en) 1989-06-19 1989-06-19 Skin cosmetics

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1156385A JP2533376B2 (en) 1989-06-19 1989-06-19 Skin cosmetics

Publications (2)

Publication Number Publication Date
JPH0320206A true JPH0320206A (en) 1991-01-29
JP2533376B2 JP2533376B2 (en) 1996-09-11

Family

ID=15626596

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1156385A Expired - Lifetime JP2533376B2 (en) 1989-06-19 1989-06-19 Skin cosmetics

Country Status (1)

Country Link
JP (1) JP2533376B2 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06345636A (en) * 1993-06-08 1994-12-20 Nonogawa Shoji Kk Cosmetic
JPH1095713A (en) * 1996-09-20 1998-04-14 Kao Corp Evaluation of improvement effect for slack of skin
WO1998040045A1 (en) * 1997-03-11 1998-09-17 Pola Chemical Industries Inc. Method for evaluating skin conditioning agents and process for producing external skin preparations
JP2001072567A (en) * 1999-09-07 2001-03-21 Sunstar Inc Skin cosmetic
WO2004098632A1 (en) * 2003-05-07 2004-11-18 Snow Brand Milk Products Co., Ltd. Skin collagen production promoter

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5754108A (en) * 1980-08-19 1982-03-31 Stauffer Chemical Co HOEETANPAKUSHITSUGANJUKESHOHINSHOHO
JPS63269947A (en) * 1987-04-29 1988-11-08 San Ei Chem Ind Ltd Fat-or oil-containing product
JPH01254610A (en) * 1988-04-01 1989-10-11 Sanko Seibutsu Kagaku Kenkyusho:Kk Skin cosmetic and production thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5754108A (en) * 1980-08-19 1982-03-31 Stauffer Chemical Co HOEETANPAKUSHITSUGANJUKESHOHINSHOHO
JPS63269947A (en) * 1987-04-29 1988-11-08 San Ei Chem Ind Ltd Fat-or oil-containing product
JPH01254610A (en) * 1988-04-01 1989-10-11 Sanko Seibutsu Kagaku Kenkyusho:Kk Skin cosmetic and production thereof

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06345636A (en) * 1993-06-08 1994-12-20 Nonogawa Shoji Kk Cosmetic
JPH1095713A (en) * 1996-09-20 1998-04-14 Kao Corp Evaluation of improvement effect for slack of skin
WO1998040045A1 (en) * 1997-03-11 1998-09-17 Pola Chemical Industries Inc. Method for evaluating skin conditioning agents and process for producing external skin preparations
JP2001072567A (en) * 1999-09-07 2001-03-21 Sunstar Inc Skin cosmetic
WO2004098632A1 (en) * 2003-05-07 2004-11-18 Snow Brand Milk Products Co., Ltd. Skin collagen production promoter

Also Published As

Publication number Publication date
JP2533376B2 (en) 1996-09-11

Similar Documents

Publication Publication Date Title
US6541447B1 (en) Wound healing composition and method for use thereof
JPH08231370A (en) Skin cosmetic
EP1265570B1 (en) Soluble keratin peptide
JPH09512563A (en) Extract of shark cartilage having anti-angiogenic activity and effect on tumor regression, and method for producing the same
US8722108B2 (en) Cosmetic and/or pharmaceutical composition comprising an extract of carob as active agent for activating aquaporin expression
EP0711171B1 (en) A pharmaceutical or cosmetic composition comprising a colostrum fraction and its medical use
PL187989B1 (en) Shark cartilage extracts, method of obtaining such extracts and compositions containing them
JPH05230100A (en) Protein fraction, its isolation, effective substance concentrate containing said fraction and preparation for skin care and/or medical treatment of inflammatory skin
JP4441123B2 (en) Use of rosmarinus plant extracts in compositions for treating signs of aging skin
JP4291967B2 (en) Skin collagen production promoter
CN110538312A (en) skin wound repair ointment and preparation method thereof
US6506732B1 (en) Enzymatic hydrolysate of milk proteins
KR100828107B1 (en) A cosmetic composition containing an extract of Ailanthus altissima
JP4698935B2 (en) Skin collagen production promoter
JPH0320206A (en) Skin cosmetic
JPH069422A (en) Promoter for biosynthesis of hyaluronic acid
AU2014253131A1 (en) Synergistic combination of alanine-glutamine, hyaluronic acid and an oat extract and the use thereof in a composition intended for healing wounds and repairing skin lesions
JP3213189B2 (en) Hyaluronic acid production promoter
JP3073862B2 (en) Hyaluronic acid production promoter
US4908206A (en) Extracts of embryonic organs, process for their preparation and pharmaceutical preparation containing them
CN110876698B (en) Active composition for regulating microenvironment of skin cells as well as preparation method and application thereof
JPH0665041A (en) Skin external preparation
US20030130195A1 (en) Enzymatic hydrolysate of milk proteins
JPH0710740A (en) Melamine production-inhibiting agent
JPH06128140A (en) External agent for skin

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080627

Year of fee payment: 12

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090627

Year of fee payment: 13

EXPY Cancellation because of completion of term
S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R370 Written measure of declining of transfer procedure

Free format text: JAPANESE INTERMEDIATE CODE: R370